Investors Sell SPDR S&P Biotech (XBI) on Strength (XBI)

Traders sold shares of SPDR S&P Biotech (NYSEARCA:XBI) on strength during trading on Thursday. $62.20 million flowed into the stock on the tick-up and $139.96 million flowed out of the stock on the tick-down, for a money net flow of $77.76 million out of the stock. Of all equities tracked, SPDR S&P Biotech had the 15th highest net out-flow for the day. SPDR S&P Biotech traded up $1.11 for the day and closed at $100.84

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, June 20th. Shareholders of record on Monday, June 18th were issued a $0.0585 dividend. The ex-dividend date was Friday, June 15th. This represents a $0.23 annualized dividend and a yield of 0.23%.

Several institutional investors and hedge funds have recently modified their holdings of XBI. Clal Insurance Enterprises Holdings Ltd bought a new position in shares of SPDR S&P Biotech in the 1st quarter valued at $118,628,000. CI Investments Inc. bought a new position in shares of SPDR S&P Biotech in the 1st quarter valued at $52,366,000. JPMorgan Chase & Co. increased its stake in shares of SPDR S&P Biotech by 64.5% in the 1st quarter. JPMorgan Chase & Co. now owns 1,462,600 shares of the exchange traded fund’s stock valued at $128,314,000 after purchasing an additional 573,431 shares during the last quarter. Whittier Trust Co. increased its stake in shares of SPDR S&P Biotech by 6,985.1% in the 1st quarter. Whittier Trust Co. now owns 136,389 shares of the exchange traded fund’s stock valued at $11,964,000 after purchasing an additional 134,464 shares during the last quarter. Finally, Barometer Capital Management Inc. bought a new position in shares of SPDR S&P Biotech in the 1st quarter valued at $6,308,000.

About SPDR S&P Biotech

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply